{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "REGULAR", "regularMarketPrice": 2.165, "regularMarketChangePercent": -2.0362024, "exchange": "ASE", "shortName": "Protalix BioTherapeutics, Inc. ", "longName": "Protalix BioTherapeutics, Inc.", "messageBoardId": "finmb_941520", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "twoHundredDayAverage": 1.5252, "twoHundredDayAverageChange": 0.63979995, "twoHundredDayAverageChangePercent": 0.41948593, "marketCap": 186714128, "forwardPE": 3.436508, "priceToBook": -10.934343, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.045000076, "regularMarketTime": 1684262532, "regularMarketDayHigh": 2.21, "regularMarketDayRange": "2.11 - 2.21", "regularMarketDayLow": 2.11, "regularMarketVolume": 1579925, "regularMarketPreviousClose": 2.21, "bid": 2.16, "ask": 2.17, "bidSize": 12, "askSize": 14, "fullExchangeName": "NYSE American", "financialCurrency": "USD", "regularMarketOpen": 2.2, "averageDailyVolume3Month": 2056288, "averageDailyVolume10Day": 4946430, "fiftyTwoWeekLowChange": 1.165, "fiftyTwoWeekLowChangePercent": 1.165, "fiftyTwoWeekRange": "1.0 - 3.55", "fiftyTwoWeekHighChange": -1.385, "fiftyTwoWeekHighChangePercent": -0.39014086, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 3.55, "dividendDate": 1576800000, "earningsTimestamp": 1683203400, "earningsTimestampStart": 1692010740, "earningsTimestampEnd": 1692360000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.27, "epsForward": 0.63, "epsCurrentYear": 0.16, "priceEpsCurrentYear": 13.53125, "sharesOutstanding": 65414900, "bookValue": -0.198, "fiftyDayAverage": 2.3506, "fiftyDayAverageChange": -0.18560004, "fiftyDayAverageChangePercent": -0.07895858, "firstTradeDateMilliseconds": 895239000000, "priceHint": 4, "displayName": "Protalix BioTherapeutics", "symbol": "PLX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2 University Plaza", "address2": "Suite 100", "city": "Hackensack", "state": "NJ", "zip": "07601", "country": "United States", "phone": "201 696 9345", "website": "https://www.protalix.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. It also develops PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is based in Hackensack, New Jersey. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.", "fullTimeEmployees": 193, "companyOfficers": [{"maxAge": 1, "name": "Mr. Dror  Bashan", "age": 55, "title": "Pres, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 473156, "fmt": "473.16k", "longFmt": "473,156"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 15938, "fmt": "15.94k", "longFmt": "15,938"}}, {"maxAge": 1, "name": "Mr. Eyal  Rubin M.B.A.", "age": 46, "title": "Sr. VP, CFO, Treasurer & Corp. Sec.", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 813725, "fmt": "813.73k", "longFmt": "813,725"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 7438, "fmt": "7.44k", "longFmt": "7,438"}}, {"maxAge": 1, "name": "Mr. Yaron  Naos", "age": 58, "title": "Sr. VP of Operations", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 409955, "fmt": "409.95k", "longFmt": "409,955"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 7225, "fmt": "7.22k", "longFmt": "7,225"}}, {"maxAge": 1, "name": "Ms. Yael  Fellous", "title": "VP of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}